Baillie Gifford & Co’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-538
| Closed | -$5.97K | – | 351 |
|
|
2023
Q1 | $5.97K | Hold |
538
| – | – | ﹤0.01% | 412 |
|
|
2022
Q4 | $6.57K | Hold |
538
| – | – | ﹤0.01% | 435 |
|
|
2022
Q3 | $6K | Hold |
538
| – | – | ﹤0.01% | 437 |
|
|
2022
Q2 | $6K | Hold |
538
| – | – | ﹤0.01% | 445 |
|
|
2022
Q1 | $5K | Hold |
538
| – | – | ﹤0.01% | 464 |
|
|
2021
Q4 | $6K | Hold |
538
| – | – | ﹤0.01% | 473 |
|
|
2021
Q3 | $5K | Hold |
538
| – | – | ﹤0.01% | 479 |
|
|
2021
Q2 | $5K | Hold |
538
| – | – | ﹤0.01% | 462 |
|
|
2021
Q1 | $5K | Buy |
538
+3
| +0.6% | +$28 | ﹤0.01% | 433 |
|
|
2020
Q4 | $12K | Buy |
+535
| New | +$12K | ﹤0.01% | 366 |
|